Schedule 13G ownership disclosure

BOLT BIOTHERAPEUTICS INC

Common Stock, $0.00001 par value · CUSIP: 097702203

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Renaissance Technologies LLC

    Shares: 92,925 · Class: 4.82%

  • Renaissance Technologies Holdings Corporation

    Shares: 92,925 · Class: 4.82%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-26-000063
Form type
SCHEDULE 13G/A
Filer
Bolt Biotherapeutics, Inc.
CIK
CIK 1641281
Filed
Nov 12, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub